A Reversal for Teva Pharmaceutical Industries Ltd (ADR) Is Not Near. Professional Options Traders Are Bullish

Share with your friends


In today’s session Teva Pharmaceutical Industries Ltd (ADR) (TEVA) registered an unusually high (734) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the January, 2016 call, expecting serious TEVA increase. With 734 contracts traded and 193244 open interest for the Jan, 16 contract, it seems this is a quite bullish bet. The option with symbol: TEVA160115C00065000 closed last at: $1.8 or 22.4% down. The stock decreased 0.11% or $0.07 during the last trading session, hitting $64.49. About 6.34M shares traded hands. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has risen 6.57% since May 8, 2015 and is uptrending. It has outperformed by 9.59% the S&P500.

Out of 23 analysts covering Teva Pharma (NYSE:TEVA), 16 rate it “Buy”, 0 “Sell”, while 8 “Hold”. This means 67% are positive. Teva Pharma was the topic in 16 analyst reports since July 21, 2015 according to StockzIntelligence Inc.

Teva Pharmaceutical Industries Limited is a global pharmaceutical and drug company. The company has a market cap of $66.50 billion. The Company’s generic products cover almost every major therapeutic area. It has 31.24 P/E ratio. The Firm operates its business in two divisions: Generic medicines, which makes and sells generic pharmaceutical products in several dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams, and Specialty medicines, which delivers solutions to patients and providers via medicines, devices and services.

Teva Pharmaceutical Industries Ltd - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Add Comment